Prescient Therapeutics Ltd

PTX

Company Profile

  • Business description

    Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia. Its product in the pipeline includes OmniCAR; PTX-100 and PTX-200. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single cell product.

  • Contact

    Level 4, 100 Albert Road
    South Melbourne
    MelbourneVIC3205
    AUS

    T: +61 396927222

    https://www.ptxtherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    Employees

    12

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,381.407.400.09%
CAC 407,727.9342.55-0.55%
DAX 4023,344.54257.891.12%
Dow JONES (US)41,218.8398.60-0.24%
FTSE 1008,596.3599.551.17%
HKSE22,658.98154.300.69%
NASDAQ17,844.24133.49-0.74%
Nikkei 22536,830.69378.391.04%
NZX 50 Index12,433.9312.680.10%
S&P 5005,650.3836.29-0.64%
S&P/ASX 2008,163.505.700.07%
SSE Composite Index3,309.9530.910.94%

Market Movers